Divergence in Cigarette Discontinuation Rates by Use of Electronic Nicotine Delivery Systems (ENDS): Longitudinal Findings From the United States PATH Study Waves 1–6

Author:

Kasza Karin A1ORCID,Tang Zhiqun2,Seo Young Sik1,Benson Adam F3ORCID,Creamer MeLisa R4,Edwards Kathryn C2ORCID,Everard Colm4,Chang Joanne T3ORCID,Cheng Yu-Ching3,Das Babita3,Oniyide Olusola3,Tashakkori Nicole A3,Weidner Anna-Sophie3,Xiao Haijun3,Stanton Cassandra2,Kimmel Heather L4ORCID,Compton Wilson4ORCID,Hyland Andrew1

Affiliation:

1. Department of Health Behavior, Roswell Park Comprehensive Cancer Center , Buffalo, NY , USA

2. Behavioral Health and Health Policy, Westat , Rockville, MD , USA

3. Center for Tobacco Products, US Food and Drug Administration , Silver Spring, MD , USA

4. National Institute on Drug Abuse, National Institutes of Health , Bethesda, MD , USA

Abstract

Abstract Introduction We compare real-world trends in population-level cigarette discontinuation rates among adults (ages ≥21) who smoked cigarettes, by electronic nicotine delivery systems (ENDS) use. Aims and Methods U.S nationally representative data from adults in the Population Assessment of Tobacco and Health (PATH) Study (2013/14-2021, Waves 1–6) who smoked cigarettes in the past 30 days (P30D) were analyzed (n = 13 640). The exposure was P30D ENDS use. The outcome was P30D cigarette discontinuation at biennial follow-up. Weighted trend analyses were conducted to test for differences in cigarette discontinuation trends by ENDS use. Results Between 2013/14 and 2015/16, cigarette discontinuation rates were both 16% for those who used ENDS and for those who did not; between 2018/19 and 2021, rates were ~30% for those who used ENDS and ~20% for those who did not; the time by ENDS use interaction was significant. Conclusions The relationship between adults’ ENDS use and cigarette discontinuation in the context of an expanded ENDS marketplace, new tobacco regulatory actions, and COVID-19 differs from the relationship in earlier years. Implications It is important for public health decisions to be informed by research based on the contemporary ENDS marketplace and circumstances.

Funder

National Institute on Drug Abuse

National Institutes of Health

Center for Tobacco Products

Publisher

Oxford University Press (OUP)

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3